Blogs provide window to pharmaceutical industry in India

Pharma blogs are playing an important role in shaping the future of the pharmaceutical industry in India. Many Indian online financial portal and investment firms as well as research organisations have provided a blogging platform for the pharma industry to keep itself updated with the development in the pharma world through open and uncensored discussion.

The Economic Times
http://economictimes.indiatimes.com/News/
News_By_Industry/Healthcare__Biotech/
Blogs_provide_window_to_pharmaceutical_industry_in_India/
articleshow/2681865.cms

Biotech industry revenue doubles to $2 bn in a year

The biotech industry is going great guns. The industry’s revenue revenue hit the $2-billion mark during 2006-07, up from $1 billion in 2004-05. The industry is now aiming to garner revenue of $5 billion before 2010. This sterling performance has its roots abroad. According to industry players, escalating research and development expenses and stringent policies are making manufacturers from the regulated Markets look towards India for cutting costs.

The Financial Express
http://www.financialexpress.com/news/
Biotech-industry-revenue-doubles-to-2-bn-in-a-year/256621/

India could attract $20 bn investment in 2008

The year 2007 is clearly the year that saw the rise of private equity funds. According to those tracking the industry, $13 billion (which is approximately Rs 55,000 crore) was invested in Indian markets in 2007. Simply put, a relatively new segment of investors have entered the scene and have pumped in Rs 55,000 crore into Indian companies. Ask any investment banker, and he will call the year 2007 a watershed year as all mandates for fund raising were completed and he is on track to receive a hefty bonus.

The Economic Times
http://economictimes.indiatimes.com/Market_Analysis/
Experts_forecast_20_bn_investment_in_2008/
articleshow/2661127.cms

Finland Inc targets Indian markets to boost growth

After the big rush from the US and Europe, it’s the turn of Finnish industry to set sights on India to widen its global reach. Driven by innovative products and technologies, a clutch of small- and medium-sized Finnish companies have drawn up plans to step up their India exposure. The idea is to cash in on their advancements in R&D to increase revenues and profits using India as the key base.

The Economic Times
http://economictimes.indiatimes.com/News_by_Industry/
Finland_companies_target_Indian_markets_to_boost_growth/
articleshow/2656640.cms

Global pharma MNCs find China tough

Colleen Cheng and Angel Chen, Chinese marketing executives in their 30s, should be the ideal customers for US and European drugmakers. So far, they are a tough sell. Glued to their cell phones at an expensive Beijing restaurant, the working moms would fit in at any cafe in New York or London with their fluent English and stylish clothing. They spend hundreds of dollars monthly on herbs, acupuncture and supplements. What they don’t buy are Western pharmaceuticals, like Johnson & Johnson’s cold medicine Sudafed and Sanofi-Aventis’s sleeping pill Ambien.

The Economic Times
http://economictimes.indiatimes.com/International_Business/
Global_pharma_MNCs_find_China_tough/articleshow/2651177.cms